HB152 Alabama 2013 Session

Updated Feb 27, 2026

Notable

Summary

Primary Sponsor: April WeaverSenator
Republican
Session: Regular Session 2013
Title: Controlled substances, deceptively obtaining same or similar substance from two or more practitioners prohibited, criminal penalties
Summary: HB152 prohibits deceiving to obtain the same or similar controlled substances from multiple doctors in a concurrent period and sets criminal penalties for doing so.
What This Bill Does
It makes it illegal for a person to withhold information from a doctor about other prescriptions for the same or similar controlled substances from another doctor in a concurrent period. The crime is considered complete when the prescription is delivered to the patient. First offenses are Class A misdemeanors, and a fourth or later offense within five years is a Class C felony. The bill notes it creates or amends a crime and is exempt from local funds requirements, and it becomes effective on the first day of the third month after passage and governor approval.

Who It Affects
Individuals who attempt to deceive two or more doctors to get controlled substances in a short period, who could face criminal penalties.
Medical practitioners and their staff, who may be involved in identifying deceptive practices and enforcing the penalties when deception occurs.

Key Provisions
Section 1(a): It is unlawful to deceptively obtain a controlled substance from a medical practitioner by withholding information that the person has prescriptions for the same or a similar substance from another practitioner in a concurrent time period.
Section 1(b): A violation is a Class A misdemeanor.
Section 1(c): A fourth or subsequent violation within five years becomes a Class C felony.
Section 2: The bill is exempt from local funds requirements under Amendment 621 because it defines a new crime or amends an existing crime.
Section 3: The act becomes effective on the first day of the third month following its passage and approval by the Governor.

AI-generated summary using openai/gpt-5-nano on Feb 24, 2026. May contain errors — refer to the official bill text for accuracy.
Subjects: Controlled Substances